Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oluwaseun O Babatunde

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Prenatal Diagnosis|June 11, 2026
Sickle Cell Disease: Historical Overview and Current TherapiesOluwaseun O Babatunde, Madeleine G Bibby, Anthony Atala, et al.
Prenatal Diagnosis|April 5, 2026
In Utero HSC Transplantation for Sickle Cell Disease: A Potential Therapeutic Approach That Overcomes Complications of Current TherapiesOluwaseun O Babatunde, Madeleine G Bibby, Anthony Atala, et al.
Frontiers in Immunology|January 23, 2026
Transplanted gene-modified placental cells boost FVIII activity in pediatric sheep without eliciting immunity, toxicity, or adverse eventsBrady Trevisan, Martin Rodriguez, Ritu Ramamurthy, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Prenatal Diagnosis|June 11, 2026
Sickle Cell Disease: Historical Overview and Current TherapiesOluwaseun O Babatunde, Madeleine G Bibby, Anthony Atala, et al.
Prenatal Diagnosis|April 5, 2026
In Utero HSC Transplantation for Sickle Cell Disease: A Potential Therapeutic Approach That Overcomes Complications of Current TherapiesOluwaseun O Babatunde, Madeleine G Bibby, Anthony Atala, et al.
Frontiers in Immunology|January 23, 2026
Transplanted gene-modified placental cells boost FVIII activity in pediatric sheep without eliciting immunity, toxicity, or adverse eventsBrady Trevisan, Martin Rodriguez, Ritu Ramamurthy, et al.
Pageof 1